Opinion

Video

Exploring BTKi Monotherapy in CLL: Long-Term Updates from ELEVATE-TN and SEQUOIA

Brian Hill, MD, PhD, discusses the use of BTK inhibitor monotherapy in CLL and presented recent long-term data updates from studies such as the 6-year follow-up of ELEVATE-TN and the extended follow-up from SEQUOIA.

Video Player is loading.
Current Time 0:00
Duration 5:18
Loaded: 0.00%
Stream Type LIVE
Remaining Time 5:18
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected